{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:38:06Z","timestamp":1791329886026,"version":"4.3.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T00:00:00Z","timestamp":1315008000000},"content-version":"vor","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.expneurol.2010.08.030","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T06:35:52Z","timestamp":1283582152000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-\u03b21\u201340 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage"],"prefix":"10.1016","volume":"226","author":[{"given":"Tetsad\u00ea C.B.","family":"Piermartiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia P.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe S.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreza F.","family":"de Bem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.S.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla I.","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.08.030_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.21731","article-title":"Simvastatin therapy prevents brain trauma-induced increases in \u03b2-amyloid peptide levels","volume":"66","author":"Abrahamson","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1006\/bbrc.2000.4156","article-title":"Inflammatory activation of prostaglandin production by microglial cells antagonized by amyloid peptide","volume":"280","author":"Balboa","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0015","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid-\u03b2-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0025","first-page":"164","article-title":"Inhibitor of cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice","volume":"59","author":"Cakala","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase","volume":"113","author":"Carlberg","year":"1985","journal-title":"Meth. Enzymol."},{"issue":"10","key":"10.1016\/j.expneurol.2010.08.030_bb0035","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1023\/B:NERE.0000042217.90204.8d","article-title":"Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain","volume":"29","author":"Chauhan","year":"2004","journal-title":"Neurochemistry"},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2006.07.031","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1\u201342 in the rat hippocampus in vivo","volume":"52","author":"Clarke","year":"2007","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.expneurol.2010.08.030_bb0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1523\/JNEUROSCI.2544-04.2005","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses","volume":"25","author":"Cordle","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0055","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M505268200","article-title":"Mechanisms of statin-mediated inhibition of small G-protein function","volume":"280","author":"Cordle","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1373\/clinchem.2005.057893","article-title":"Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response","volume":"52","author":"Deng","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","article-title":"Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils","volume":"382","author":"El Khoury","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2010.08.030_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulphydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-199906030-00014","article-title":"The role of cholesterol in the biosynthesis of beta-amyloid","volume":"10","author":"Frears","year":"1999","journal-title":"NeuroReport"},{"issue":"13","key":"10.1016\/j.expneurol.2010.08.030_bb0085","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000014245.25136.D2","article-title":"The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients","volume":"105","author":"Gotto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2010.08.030_bb0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","article-title":"Cholinesterase inhibitors for Alzheimer's disease","volume":"61","author":"Grutzendler","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2004.03.022","article-title":"Modulation of Na(+), K(+) pumping and neurotransmitter uptake by beta-amyloid","volume":"126","author":"Gu","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","article-title":"Amyloid beta peptide (25\u201335) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures","volume":"67","author":"Harris","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2004.12.051","article-title":"HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons","volume":"1037","author":"Hayashi","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568006013338187","article-title":"Pleiotropic effects of statins on the vascular tissue","volume":"1","author":"Ikeda","year":"2001","journal-title":"Curr. Drugs Targets Cardiovasc. Haematol. Disord."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"In t' Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2004.04.012","article-title":"Beta-amyloid (1\u201342)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex","volume":"155","author":"Jhoo","year":"2004","journal-title":"Behav. Brain"},{"key":"10.1016\/j.expneurol.2010.08.030_bb0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.expneurol.2010.08.030_bb0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.neuropharm.2005.07.014","article-title":"Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1","volume":"49","author":"Krizman-Genda","year":"2005","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.expneurol.2010.08.030_bb0145","first-page":"531","article-title":"Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model","volume":"21","author":"Kurinami","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1\u201342","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0155","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2010.08.030_bb0160","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1471-4159.2007.05044.x","article-title":"Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS\/c-Jun levels and activating ERK\/Akt pathways","volume":"104","author":"Lee","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neulet.2008.05.112","article-title":"Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death","volume":"440","author":"Lee","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"89","key":"10.1016\/j.expneurol.2010.08.030_bb0170","first-page":"118","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/089771504772695913","article-title":"Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury","volume":"21","author":"Lu","year":"2004","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.expneurol.2010.08.030_bb0180","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuroscience.2008.08.022","article-title":"Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades","volume":"156","author":"Matos","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mehy.2006.01.013","article-title":"Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders","volume":"67","author":"McCarty","year":"2006","journal-title":"Med. Hypotheses"},{"issue":"20","key":"10.1016\/j.expneurol.2010.08.030_bb0190","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"27","author":"Medeiros","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0195","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral \u03b2-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luhemann","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pharmthera.2006.09.003","article-title":"Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects","volume":"113","author":"Miida","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11064-004-9689-0","article-title":"Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP","volume":"30","author":"Molz","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0210","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4049\/jimmunol.172.2.1273","article-title":"Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy","volume":"172","author":"Nath","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0215","first-page":"351","article-title":"Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction","volume":"9","author":"Ohkawa","year":"1959","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","article-title":"Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake","volume":"16","author":"Piermartiri","year":"2009","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2010.08.030_bb0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbr.2006.11.032","article-title":"Differential susceptibility following beta-amyloid peptide-(1\u201340) administration in C57BL\/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response","volume":"177","author":"Prediger","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2010.08.030_bb0230","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuroscience.2007.11.009","article-title":"Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease","volume":"151","author":"Prediger","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.expneurol.2010.08.030_bb0235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2010.08.030_bb0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"34","key":"10.1016\/j.expneurol.2010.08.030_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03033975","article-title":"Role of astrocytes in glutamate homeostasis: implications for excitotoxicity","volume":"8","author":"Schousboe","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1092-0","article-title":"Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme","volume":"198","author":"Shaeffer","year":"2008","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.expneurol.2010.08.030_bb0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2008-13402","article-title":"Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders","volume":"13","author":"Schwab","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0260","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.08.030_bb0265","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.expneurol.2010.08.030_bb0270","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1074\/jbc.275.7.5228","article-title":"Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase","volume":"275","author":"Sims","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.expneurol.2010.08.030_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1567205054367900","article-title":"Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD","volume":"2","author":"Sparks","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0280","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.05.035","article-title":"Validation of A\u03b21\u201340 administration into mouse cerebroventricles as an animal model for Alzheimer disease","volume":"1280","author":"Takeda","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.expneurol.2010.08.030_bb0290","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2009.06.003","article-title":"Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice","volume":"35","author":"Tong","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0295","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","article-title":"Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?","volume":"19","author":"Trotti","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.expneurol.2010.08.030_bb0300","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"Van Dam","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0305","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"issue":"5A","key":"10.1016\/j.expneurol.2010.08.030_bb0310","doi-asserted-by":"crossref","first-page":"69F","DOI":"10.1016\/j.amjcard.2005.06.028","article-title":"Safety of high-dose atorvastatin therapy","volume":"96","author":"Waters","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0315","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","article-title":"NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?","volume":"28","author":"Weggen","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","article-title":"Glutathione peroxidase","volume":"77","author":"Wendel","year":"1981","journal-title":"Meth. Enzymol."},{"issue":"6","key":"10.1016\/j.expneurol.2010.08.030_bb0325","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00041433-200412000-00007","article-title":"Cholesterol, statins and dementia","volume":"15","author":"Wolozin","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.expneurol.2010.08.030_bb0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5551\/jat.10.140","article-title":"Potential role of statins in inflammation and atherosclerosis","volume":"10","author":"Yoshida","year":"2003","journal-title":"J. Atheroscler. Thromb."}],"updated-by":[{"DOI":"10.1016\/j.expneurol.2021.113840","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610003298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610003298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:42:36Z","timestamp":1758001356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610003298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0014488610003298"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.08.030","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-\u03b21\u201340 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}